Cargando…
Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study
BACKGROUND AND AIMS: To determine prevalence and clinical utility of pathogenic germline variants (PGV) in gastric and esophageal cancer patients using universal genetic testing approach. METHODS: We undertook a prospective study of germline sequencing using an > 80 gene next-generation sequencin...
Autores principales: | Uson, P. L. S., Kunze, K. L., Golafshar, M. A., Botrus, G., Riegert-Johnson, D., Boardman, L., Borad, M. J., Ahn, D., Sonbol, M. B., Kahn, A., Klint, M., Esplin, E. D., Nussbaum, R. L., Stewart, A. K., Bekaii-Saab, T., Samadder, N. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587949/ https://www.ncbi.nlm.nih.gov/pubmed/35122589 http://dx.doi.org/10.1007/s10620-022-07387-x |
Ejemplares similares
-
Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective Study
por: Uson Junior, Pedro LS, et al.
Publicado: (2022) -
Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study
por: Uson, Pedro L. S., et al.
Publicado: (2021) -
Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program
por: Jones, Jeremy C, et al.
Publicado: (2023) -
Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer
por: Esplin, Edward D., et al.
Publicado: (2022) -
The Role of Systemic Therapy in Resectable Colorectal Liver Metastases: Systematic Review and Network Meta-Analysis
por: Sonbol, Mohamad Bassam, et al.
Publicado: (2022)